Search Results 291-300 of 1336 for 下载ai官网,ai画图网站 免费,免费写作ai的网站,国外ai作画网站,ai免费算命网,等欢迎访问豌豆Ai站群搜索引擎系统官方网站:www.wd.chat

  1. A Study of the Effectiveness of LY3314814 in Patients with Mild Alzheimer's Disease Dementia - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness of LY3314814 in the treatment of people who have mild Alzheimer's disease dementia. Participation ...

  2. Young-adult normal FDG-PET database - Mayo Clinic

    About this study. The purpose of this study is to construct a young-adult normative FDG database that could be used with Cortex-ID and/or MIMneuro, ...

  3. Joel Streed | Mayo Clinic News Network - Page 155 of 170

    Marlow and Fran Cowan returned to Mayo Clinic campus in Rochester this week. You likely remember them as the couple whose piano duet became a YouTube[...] By ...

  4. A Phase 1b/2 Safety and Tolerability of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  5. Xiao Ma - Training and Education - Center for Clinical and Translational Science (CCaTS)

    Profile of Xiao Ma, a student in the Ph.D. Program at Mayo Clinic.

  6. ACORYS-AI4AF a Pilot Study - Mayo Clinic

    The purpose of this study is to develop and evaluate the capacity of novel artificial intelligence models (i.e. ACORYS-AI4AF model) to predict post-ablation ...

  7. An Extension Study to QTI571A2301 to Evaluate the Long-Term Safety, Tolerability and Effectiveness of Imatinib in Severe Pulmonary Arterial Hypertension - Mayo Clinic

    About this study. The purpose of this extension study is to provide data on the long-term safety, tolerability, and efficacy of imatinib in the treatment of ...

  8. Active Removal of IntraCerebral Hematoma Via Active Irrigation - Mayo Clinic

    Study evaluating if active irrigation by IRRAflow® with infusion of tPA will reduce the time needed for clearance of intracerebral and intraventricular ...

  9. Study of Tipifarnib in Subjects With Relapsed or Refractory Peripheral T-Cell Lymphoma - Mayo Clinic

    Tipifarnib will be administered until disease progression then followed approximately every 12 weeks for survival until either death or 12 months after accrual ...

  10. Contact - Discovery and Translation Labs - Mayo Clinic Research

    Contact the Discovery and Translation Labs brain research area about research on Alzheimer's disease, dementia, frontotemporal degeneration, amyotrophic lateral ...